Literature DB >> 30663553

Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganisms.

Cagla Bozkurt Guzel1, Ozlem Oyardi1, Paul B Savage2.   

Abstract

Ceragenins, a novel family of antibiotics, are cationic derivatives of cholic acid and display broad-spectrum antimicrobial activities. Multiple ceragenins have been synthesized and studied, and most published data are with ceragenin CSA-13. This study aimed to investigate the in vitro antimicrobial properties of second-generation ceragenins, CSA-142 and CSA-192, and compare them to CSA-13. The antimicrobial activities of CSA-13, CSA-142 and CSA-192 were studied against 20 strains of Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans. Time-kill curve methods were performed to determine the bactericidal and fungicidal activities of the ceragenins against three strains of each microorganism. Overall, CSA-13 showed the lowest MIC values, but also CSA-142 and CSA-192 had good activities against tested microorganisms. The killing curves showed that ceragenins generally had bactericidal and fungicidal effects. The bactericidal and fungicidal behaviours of CSA-142 and CSA-192 may make them good alternative agents to CSA-13.

Entities:  

Keywords:  activities; Ceragenins; Dynamic time-kill experiments

Mesh:

Substances:

Year:  2018        PMID: 30663553     DOI: 10.1080/1120009X.2018.1534567

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  4 in total

1.  NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131.

Authors:  Sylwia Joanna Chmielewska; Karol Skłodowski; Ewelina Piktel; Łukasz Suprewicz; Krzysztof Fiedoruk; Tamara Daniluk; Przemysław Wolak; Paul B Savage; Robert Bucki
Journal:  Infect Drug Resist       Date:  2020-09-28       Impact factor: 4.003

2.  Antibacterial and Antibiofilm Activities of Ceragenins against Pseudomonas aeruginosa Clinical Isolates.

Authors:  Çağla Bozkurt Güzel; Mayram Hacioğlu; Gözde Inci; Paul B Savage
Journal:  Turk J Pharm Sci       Date:  2019-11-11

3.  New β-Lactam Antibiotics and Ceragenins - A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of Pseudomonas aeruginosa.

Authors:  Paulina Paprocka; Bonita Durnaś; Angelika Mańkowska; Karol Skłodowski; Grzegorz Król; Magdalena Zakrzewska; Michał Czarnowski; Patrycja Kot; Kamila Fortunka; Stanisław Góźdź; Paul B Savage; Robert Bucki
Journal:  Infect Drug Resist       Date:  2021-12-25       Impact factor: 4.003

Review 4.  Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications.

Authors:  Urszula Wnorowska; Krzysztof Fiedoruk; Ewelina Piktel; Suhanya V Prasad; Magdalena Sulik; Marianna Janion; Tamara Daniluk; Paul B Savage; Robert Bucki
Journal:  J Nanobiotechnology       Date:  2020-01-02       Impact factor: 10.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.